Composition

One mL solution of injection contains: Brolucizumab 120 mg Excipients q.s.  

ATC Code

S01LA06  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 0.23 mL (in vial/pre-filled syringe)  

Product Description

Solution for Injection PAGENAX®/™ is supplied in a single-use vial or in a single-use pre-filled syringe Vial: Sterile, clear to slightly opalescent, colorless to slightly brownish-yellow and preservative-free aqueous solution Single use. 0.23 mL in 1 mL Ph. Eur. Type I colourless glass vial with grey rubber stoppper and an aluminum seal with violet flip-off cap +1 1⁄2" 18G filter needle in a soft blister (Box of 1's).

Manufacturer Name

Novartis Pharma Produktions GmbH

Manufacturer Country

GERMANY  

Approval Date

2023-04-02  

Expiry Date

2028-03-29